Hsa-miR-96 and hsa-miR-217 expression downregulates with increasing dysplasia in pancreatic intraepithelial neoplasias and intraductal papillary mucinous neoplasms

To compare the clinicopathological features of pancreatic intraepithelial neoplasias(PanINs) and intraductal papillary mucinous neoplasms (IPMNs), and to investigate the role of hsa-miR-96 and hsa-miR-217 in these two lesions.